Varsity OnlineAntibodies: Medicine EvolvedVarsity OnlineAntibodies: Medicine Evolved. Nick Hudson looks at the growing applications of antibodies: Natural weapons in the fight against infectious disease which are proving their worth against cancer and …
Research and Markets: Competitor Analysis: TNF Antibodies – Biosimilars and …The Herald | HeraldOnline.com (press release)The present Competitive Intelligence Report about TNF Antibodies -Biosimilars and Biosuperiors provides a competitor evaluation …
Research and Markets: Competitor Analysis: TNF Antibodies – Biosimilars and …Business Wire (press release)The present Competitive Intelligence Report about TNF Antibodies -Biosimilars and Biosuperiors provides a competitor evaluation in the field of …
Research and Markets: Competitor Analysis: Her2 Antibodies – Trastuzumab …Business Wire (press release)The present Competitive Intelligence Report about Her2 Antibodies – Trastuzumab Biosimilars and Biobetters/Biosuperiors provides a competitor evalu…
|
Biosimilar Monoclonal Antibodies Emerge From The Pipeline On Both Sides Of …
Mondaq News Alerts (registration) The European Medicines Agency (“EMEA”) made its biosimilar monoclonal antibody guidelines effective in December 20121. Less than a year later, in September 2013, it approved Europe’s first biosimilar antibody. The drug is Inflectra which is a … |
HIV vaccine hope found in immune system of a unique patientMedical News TodayThe Journal of Clinical Investigation has published a new study of a unique patient with an immune system that produces the types of neutralizing antibodies that are considere…
iStockAnalyst (press release)Biogen Idec Inc (BIIB): Pipeline Offers Several Transformational OpportunitiesiStockAnalyst (press release)Upside potential beyond current estimates would include commercial success of Plegridy and daclizumab in Relapsing R…
Research and Markets: Competitor Analysis: EGF-R Antibodies – Biosimilars and …Business Wire (press release)The present Competitive Intelligence Report about EGF-R Antibodies -Biosimilars and Biosuperiors provides a competitor evaluation in the field…
Idelalisib plus rituximab improves progression-free survival in relapsed CLL2 Minute Medicine1. Idelalisib plus rituximab improved progression-free survival in patients with relapsing CLL compared to rituximab plus placebo. This benefit was seen across…
Research and Markets: Competitor Analysis: Biosimilar and Biosuperior …Business Wire (press release)The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field…